Scientists from ITMO University, the Federal Research and Clinical Centre of Physical-Chemical Medicine and MIPT have developed a software program enabling them to quickly compare sets of DNA of microorganisms living in different environments. The researchers have already suggested exactly how the new program could be applied in practice. Using the algorithm to compare the microflora of a healthy person with the microflora of a patient, specialists would be able to detect previously unknown pathogens and their strains, which can aid the development of personalized medicine.
The results of the study have been published in Bioinformatics.
Every person has a genome – a specific sequence of genes according to which an individual develops. However, any living organism contains another gene sequence that is called the metagenome.It is the total DNA content of the many different microorganisms that inhabit the same environment – bacteria, fungi, and viruses. The metagenome is often indicative of various diseases or predispositions to such diseases. Studying microbiota, i.e. the full range of microorganisms inhabiting different parts of the human body, has thereforea criticalrole in metagenomic research.
The software tool developed by the scientists and called MetaFast is able to conduct a rapid comparative analysis of large amounts of metagenomes. “In studying the intestinal microflora of patients, we may be able to detect microorganisms associated with a particular disease, such as diabetes, or a predisposition to the disease. This already forms a basis for applying personalized medicine techniques and developing new drugs. Using the results obtained with the software, biologists will be able to draw conclusions on how to further develop their research, because the algorithm enables them to study environments that we currently know nothing about,” says Vladimir Ulyantsev, lead developer of the algorithm and researcher at the Computer Technologies Laboratory at ITMO University.
One of the key benefits of the program is that it is able to work successfully with environments in which the genetic contents have not yet been studied. “The newly developed approach allows us to do two things – find all the possible gene sequences, even if they were previously unknown (the program collects them from fragments of genomic reads), and at the same time identify metagenomic patterns that distinguish one patient from another, e.g. people with and without a disease,” says Dmitry Alexeev, the leader of the project and head of MIPT’s Laboratory of Complex Biological Systems.
This means that the program can be used to conduct an untargeted express analysis of markers indicating certain diseases. Then, by using targeted methods such as PCR (a technique to make multiple copies of a fragment of DNA), the results can be verified and adjusted. According to the researchers, the program could greatly reduce the time needed to develop new drugs.
Microorganisms that do not reproduce in vitro, such as viruses, give very abstract results in tests and it is not possible to collect their DNA. However, the new program is able to detect even these microorganisms. “In the microbiota of the skin alone, 90% of the organisms are unknown,” continues Dmitry Alexeev. “Our approach enables us to work with completely unknown material and still obtain results. The program has been tested in a wide variety of environments, including those with a high number of viruses. The program is even able to locate and collect single DNA strands.”
MetaFast is not limited to detecting pathogens. For example, the program canalso be used to compare distinct peoples in closed populations with people living in cities to help identify bacterial strains that are extremely useful to humans, but have been lost in the process of urbanization. Antibiotics, preservatives, colorants and supermarket food have pushedmany useful bacteria out of our microflora, but these bacteria could still be present in closed populations, such as American Indians or people in Russian villages.
MetaFast has proven to be highly effective in studying rare and undiscovered metagenomes. As a part of the study, the scientists analysed the metagenome of several of the world’s largest lakes. Without any information about the samples of microbiota from the lakes, the program found genetic similarities between samples that were close in terms of their chemical composition.
The researchers also used the new algorithm to study the inhabitants of the New York underground, demonstrating the effectiveness of the algorithm when analysing such complex systems. Most of the DNA collectedusing MetaFast belonged to already known bacteria. This confirms previous theories stating that the subway is safe for humans, and the microbes that live there suppress any flora that could be dangerous to people.
A vast amount of experimental data has already been gathered worldwide on various metagenomes. As the cost of extracting DNA is decreasing and the sensitivity of equipment is increasing, the volume of data is continuing to grow exponentially. Despite this, most of the studies have not been fully completed. The reason lies in the limitations of the current technology. On the one hand, scientists are able to partially collect a metagenome, but piecing together the “puzzle” takes an enormous amount of time. On the other hand, they can compare individual fragmentsof the genome with existing DNA references, but there are very limited numbers of bacteria, and virtually no viruses.
The new algorithm not only combines the advantages of both of these approaches, but also enables data to be processed at high speed. The program saves RAM because it partially collects and partially compares genomes, but does not go into an in-depth collection analysis.
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Ted Snelgrove Joins Personalized Medicine Foundation Board of Directorson November 23, 2020 at 9:08 am
The Personalized Medicine Foundation (PMF) a leading cancer patient advocacy organization focused on patient education ...
- Estonian social affairs minister establishes personalized medicine councilon November 23, 2020 at 4:27 am
Minister of Social Affairs Tanel Kiik (Center) on Friday formed the personalized medicine council, the aim of which is to compile a comprehensive long-term program for the development of personalized ...
- UTHSC collaborates with Regeneron to advance precision medicine in the mid-southon November 19, 2020 at 12:17 pm
The University of Tennessee Health Science Center has entered into an agreement with the Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, Inc., for the company to sequence DNA ...
- Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and Chinaon November 15, 2020 at 10:05 pm
(GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced today the expansion of Myriad myChoice ® tumor testing in several ...
- Personalized Medicine Market, 2029on November 11, 2020 at 3:45 am
DUBLIN, Nov. 11, 2020 /PRNewswire/ -- The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The concept ...
- Global Personalized Medicine Markets Report 2020: Focus on Scientific Basis & Technologies and Markets & Companies - ResearchAndMarkets.comon November 4, 2020 at 4:16 am
DUBLIN--(BUSINESS WIRE)--The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The concept of ...
- Personalized Medicine Market 2020: Industry Trends and Growth Rate, Product & Application Segmentation, Key Companies and Regional Analysis by 2026on November 4, 2020 at 3:48 am
Nov 04, 2020 (The Expresswire) -- The report “Personalized Medicine Market” in Global to 2026 - Market Scope, Development, and Predictions offers the most up-to-date industry information on ...
- Global Personalized Medicine Markets Report 2020: Focus on Scientific Basis & Technologies and Markets & Companies - ResearchAndMarkets.comon November 4, 2020 at 3:38 am
The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The concept of personalized medicine described in this ...
- Biobanks Are Becoming Data Banks in the Era of Personalized Medicineon November 3, 2020 at 4:00 am
These models are enabling the future of personalized medicine.” Long-term storage of healthy tissue is a growing area of demand as a result of the aging global population. “The biobanking of ...
- Global Personalized Medicine Scientific & Commercial Aspects Market Report 2020-2029 with Profiles of 298 Companies Along with 583 Collaborationson October 30, 2020 at 1:13 am
Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Personalized Medicine - Scientific & Commercial Aspects" report from Jain ...
via Bing News